Stockscreener 앱 받기
12.92
0.62%
-0.08
전일 마감가:
$13.00
열려 있는:
$13.04
하루 거래량:
92,053
Relative Volume:
0.42
시가총액:
$80.67M
수익:
-
순이익/손실:
$-14.56M
주가수익비율:
-0.7681
EPS:
-16.82
순현금흐름:
$-12.46M
1주 성능:
+4.53%
1개월 성능:
-12.11%
6개월 성능:
+119.35%
1년 성능:
+71.81%
1일 변동 폭
$12.60
$13.21
1주일 범위
$12.20
$14.08
52주 변동 폭
$4.63
$18.38
Tenax Therapeutics Inc Stock (TENX) Company Profile
명칭
Tenax Therapeutics Inc
전화
919-855-2100
주소
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Compare TENX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TENX
Tenax Therapeutics Inc
|
12.92 | 81.17M | 0 | -14.56M | -12.46M | -16.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-08 | 개시 | Piper Sandler | Overweight |
| 2024-10-24 | 개시 | Leerink Partners | Outperform |
| 2024-10-14 | 개시 | Guggenheim | Buy |
| 2024-09-30 | 개시 | William Blair | Outperform |
| 2017-05-18 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2014-12-16 | 개시 | MLV & Co | Buy |
| 2014-11-18 | 개시 | WallachBeth | Buy |
모두보기
Tenax Therapeutics Inc 주식(TENX)의 최신 뉴스
Tenax Therapeutics (NASDAQ:TENX) Stock Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
Responsive Playbooks and the TENX Inflection - Stock Traders Daily
Bear Alert: What hedge funds are buying Tenax Therapeutics IncWeekly Earnings Recap & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200 Day Moving AverageShould You Sell? - MarketBeat
Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200 Day Moving Average – Should You Sell? - Defense World
Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 - Investing News Network
Risk Report: Is Harris Oakmark Etf Trust stock a hidden gemQuarterly Trade Summary & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Fundamentals Check: What is the next catalyst for Tenax Therapeutics IncPortfolio Return Summary & AI Forecasted Stock Moves - baoquankhu1.vn
Is Tenax Therapeutics Inc. still a buy after recent gains2025 Market Overview & Safe Capital Growth Tips - mfd.ru
Understanding the Setup: (TENX) and Scalable Risk - Stock Traders Daily
Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200-Day Moving AverageHere's Why - MarketBeat
Aug Macro: Is Tenax Therapeutics Inc forming a double bottomWall Street Watch & Proven Capital Preservation Tips - baoquankhu1.vn
Aug Movers: Will CPSP face regulatory challengesTrade Risk Assessment & Risk Managed Investment Entry Signals - baoquankhu1.vn
Financial Survey: Biorestorative Therapies (NASDAQ:BRTX) vs. Tenax Therapeutics (NASDAQ:TENX) - Defense World
The Technical Signals Behind (TENX) That Institutions Follow - Stock Traders Daily
Investment Review: Can Tenax Therapeutics Inc stock outperform in 2025 bull marketPortfolio Growth Summary & Low Drawdown Investment Strategies - Bộ Nội Vụ
Published on: 2026-01-14 00:08:43 - Bộ Nội Vụ
Tenax Therapeutics (NASDAQ:TENX) Share Price Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Tenax Therapeutics (NASDAQ:TENX) Is In A Good Position To Deliver On Growth Plans - Sahm
Guggenheim doubles Tenax (TENX) PT, names stock top pick - MSN
Tenax Therapeutics Stock: A Speculative Buy (NASDAQ:TENX) - Seeking Alpha
How Tenax Therapeutics Inc. stock reacts to oil prices2025 Trading Recap & Real-Time Stock Entry Alerts - Улправда
Is Tenax Therapeutics Inc. stock cheap at current valuationJuly 2025 Selloffs & Daily Profit Maximizing Tips - Улправда
Why Tenax Therapeutics Inc. stock is considered a top pickJuly 2025 Big Picture & AI Forecasted Stock Moves - ulpravda.ru
Guggenheim Doubles Tenax (TENX) PT, Names Stock Top Pick - Finviz
Will Tenax Therapeutics Inc. stock see insider buyingRisk Management & Low Drawdown Trading Techniques - Улправда
Earnings Beat: Is Tenax Therapeutics Inc. stock overvalued by current metrics2025 Support & Resistance & Risk Managed Investment Signals - Улправда
Is Tenax Therapeutics Inc. stock near bottom after declineWeekly Trend Report & Low Volatility Stock Suggestions - Улправда
What is the fair value of Tenax Therapeutics Inc. stock nowEarnings Performance Report & Real-Time Buy Signal Notifications - Улправда
Precision Trading with Tenax Therapeutics Inc. (TENX) Risk Zones - Stock Traders Daily
Tenax Therapeutics: How Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing - Seeking Alpha
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
Tenax Therapeutics Inc. (TENX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How Tenax Therapeutics Inc. (TENX) Affects Rotational Strategy Timing - Stock Traders Daily
Tenax Therapeutics (NASDAQ:TENX) Stock Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
Growth Value: Will Tenax Therapeutics Inc stock see insider buyingGold Moves & Low Risk Growth Stock Ideas - Bộ Nội Vụ
Tenax Therapeutics (TENX) Price Target Increased by 12.22% to 25.76 - Nasdaq
Is Tenax Therapeutics Inc. stock overvalued by current metricsJuly 2025 Spike Watch & Fast Exit and Entry Strategy Plans - DonanımHaber
Roth MKM Reaffirms Their Buy Rating on Tenax Therapeutics (TENX) - The Globe and Mail
Is Tenax Therapeutics Inc. stock supported by strong cash flowsMarket Movers & Low Drawdown Investment Ideas - DonanımHaber
Tenax Therapeutics (NASDAQ:TENX) Stock Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Can Tenax Therapeutics Inc. stock beat market expectations this quarter2025 Technical Patterns & Safe Capital Growth Stock Tips - Улправда
Tenax Therapeutics (NASDAQ:TENX) Stock Crosses Above 200 Day Moving AverageWhat's Next? - MarketBeat
Guggenheim Maintains Tenax Therapeutics (TENX) Buy Recommendation - Nasdaq
Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target By Investing.com - Investing.com Canada
[8-K] TENAX THERAPEUTICS, INC. Reports Material Event | TENX SEC FilingForm 8-K - Stock Titan
Tenax Therapeutics (TENX) Updates on Clinical Trials and New Ini - GuruFocus
Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target - Investing.com
Tenax Therapeutics level trial on track to complete enrollment in H1 2026 - marketscreener.com
Tenax Therapeutics Confirms Enrollment Target for LEVEL Study; Initiates LEVEL-2 Phase 3 Study for TNX-103 - Quiver Quantitative
Tenax Therapeutics Inc (TENX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
0.19%
자본화:
|
볼륨(24시간):